Case Report: A Novel MVK Missense Mutation in the Sporadic Porokeratosis Ptychotropica in China.

MVK PPt genetic testing mevalonate pathway missense mutations

Journal

Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449

Informations de publication

Date de publication:
2023
Historique:
received: 10 02 2023
accepted: 10 05 2023
medline: 30 5 2023
pubmed: 30 5 2023
entrez: 30 5 2023
Statut: epublish

Résumé

Porokeratosis ptychotropica (PPt) is a rare type of porokeratosis (PK) characterized by pruritic, reddish-brownish verrucous papules, and plaques usually around genital area or buttocks. Here, a case of a 70-year-old woman who was diagnosed as PPt was reported. The patient suffered from severe pruritic papules and plaques in the buttock region and pubis for 4 years. The skin lesions were giant, well-defined brown plaques with many satellite papules scattered around. Both clinical manifestations and histopathological features supported the diagnosis of PPt. In review of the identified mutation was found in patients with disseminated superficial actinic porokeratosis (DSAP) combined with PPt, while its unclear in PPt. To investigate the hypothesis that the variant reported in the present case report may played as an independent "likely pathogenic factor" of PPt. Consequently, a de novo missense pathogenic mutation in the MVK gene was identified in this case. Unexpectedly, it is a first report of a novel MVK mutation in sporadic PPt. This rare case suggested an isogenetic background between PPt and DSAP, which may help to explore the underlying pathogenesis of PPt.

Identifiants

pubmed: 37250911
doi: 10.2147/CCID.S408016
pii: 408016
pmc: PMC10224681
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1325-1329

Informations de copyright

© 2023 Mei et al.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

JAMA Dermatol. 2019 May 1;155(5):548-555
pubmed: 30942823
Elife. 2015 Jul 23;4:e06322
pubmed: 26202976
Front Chem. 2014 Jul 22;2:50
pubmed: 25101260
Australas J Dermatol. 2023 Feb;64(1):e72-e75
pubmed: 36320094
JAMA Dermatol. 2019 Jul 1;155(7):845
pubmed: 31090870
J Dermatol. 2021 Mar;48(3):e137-e139
pubmed: 33458876
World J Clin Cases. 2022 May 16;10(14):4528-4534
pubmed: 35663074
Br J Dermatol. 1995 Jan;132(1):150-1
pubmed: 7756129
J Am Acad Dermatol. 2010 Nov;63(5):886-91
pubmed: 20451293
J Dermatol. 2002 Nov;29(11):681-92
pubmed: 12484429

Auteurs

Qin Mei (Q)

Department of Dermatology, Dermatology Hospital of Fuzhou, Fuzhou, Fujian, People's Republic of China.

Fengling Xing (F)

Department of Dermatology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.

Yue Yin (Y)

Department of Dermatology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.

Chengda Yuan (C)

Department of Dermatology, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China.

Classifications MeSH